About Pearl Bio
Pearl Bio is a synthetic biology company recording life to create a new era of biologics and biomaterials.
Company details
Funding
Total raised
$4.1M
Last stage
Seed
Investors
Founders
Farren Isaacs
Professor at Yale University; scientific co-founder of Pearl Bio. His lab's research on genomically recoded organisms and genome recoding forms the basis of Pearl Bio's platform technology.
Michael Jewett
Professor in Bioengineering at Stanford University; scientific co-founder of Pearl Bio. Serial biotech co-founder; his lab's work on ribosome engineering and cell-free systems underpins Pearl Bio's technology.
Amy Cayne Schwartz
Spearheads operations, business strategy, and serves as General Counsel for Pearl Bio. Former attorney at Cadwalader, Wickersham & Taft and Nixon Peabody; also President and General Counsel of Genome Project-write (GP-write).
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.